<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Pediatric Hematology/Oncology and Immunopathology</journal-id><journal-title-group><journal-title xml:lang="en">Pediatric Hematology/Oncology and Immunopathology</journal-title><trans-title-group xml:lang="ru"><trans-title>Вопросы гематологии/онкологии и иммунопатологии в педиатрии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-1708</issn><issn publication-format="electronic">2414-9314</issn><publisher><publisher-name xml:lang="en">Fund Doctors, Innovations, Science for Children</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">188</article-id><article-id pub-id-type="doi">10.24287/1726-1708-2018-17-3-28-34</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Association between congenital heart disease and neuroblastoma in children</article-title><trans-title-group xml:lang="ru"><trans-title>Ассоциация врожденных пороков сердца и нейробластомы у детей</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3767-4477</contrib-id><name-alternatives><name xml:lang="en"><surname>Shamanskaya</surname><given-names>T. V.</given-names></name><name xml:lang="ru"><surname>Шаманская</surname><given-names>Т. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p><italic>Tatyana V. Shamanskaya,</italic> MD, scientific secretary</p><p>117997, Moscow, Samory Mashela st., 1</p></bio><bio xml:lang="ru"><p><italic>Шаманская Татьяна Викторовна,</italic> канд. мед. наук, ученый секретарь </p><p>врач-онколог отделения клинической онкологии </p><p>117997, Москва, ГСП-7, ул. Саморы Машела, 1</p></bio><email>shamanskaya.tatyana@gmail.com</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1925-2457</contrib-id><name-alternatives><name xml:lang="en"><surname>Burgol</surname><given-names>M. M.</given-names></name><name xml:lang="ru"><surname>Бургол</surname><given-names>М. М.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3704-8783</contrib-id><name-alternatives><name xml:lang="en"><surname>Kachanov</surname><given-names>D. Yu.</given-names></name><name xml:lang="ru"><surname>Качанов</surname><given-names>Д. Ю.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Rybalko</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Рыбалко</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pankratieva</surname><given-names>L. L.</given-names></name><name xml:lang="ru"><surname>Панкратьева</surname><given-names>Л. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sugak</surname><given-names>A. B.</given-names></name><name xml:lang="ru"><surname>Сугак</surname><given-names>А. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Feoktistova</surname><given-names>E. V.</given-names></name><name xml:lang="ru"><surname>Феоктистова</surname><given-names>Е. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Varfolomeeva</surname><given-names>S. R.</given-names></name><name xml:lang="ru"><surname>Варфоломеева</surname><given-names>С. Р.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Institute of oncology, radiology and nuclear medicine</institution></aff><aff><institution xml:lang="ru">Института онкологии, радиологии и ядерной медицины</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Dmitriy Rogachev National Medical Research Center of Pediatric Hematology, Oncology, Immunology Ministry of Healthcare of Russian Federation</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-09-24" publication-format="electronic"><day>24</day><month>09</month><year>2018</year></pub-date><volume>17</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>28</fpage><lpage>34</lpage><history><date date-type="received" iso-8601-date="2018-09-23"><day>23</day><month>09</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-09-23"><day>23</day><month>09</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, «D. Rogachev NMRCPHOI»</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">«D. Rogachev NMRCPHOI»</copyright-holder><copyright-holder xml:lang="ru">ФГБУ «НМИЦ ДГОИ им. Дмитрия Рогачева» Минздрава России</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://hemoncim.com/jour/article/view/188">https://hemoncim.com/jour/article/view/188</self-uri><abstract xml:lang="en"><p>We have analyzed the association between the most common extracranial solid tumor of childhood neuroblastoma (NB) and congenital heart disease (CHD) based on our own data and literature review. The analyses was carried out based on medical history and  echocardiography data of NB patients, who received medical treatment in Dmitriy Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology. 11 out of 457 patients with NB had CHD, the most common diagnosis was ventricular septal defect. The epidemiologic data of the cohort of patients with CHD and NB was presented. The article contains detailed description of two patients with CHD and localized and metastatic NB. The comprehensive analysis of the existing literature was done. In conclusion, CHD was observed in 2,4% cases. All patients with NB are required cardiologic assessment including echocardiography.</p></abstract><trans-abstract xml:lang="ru"><p>В работе представлен анализ ассоциации наиболее часто встречающейся экстракраниальной солидной опухоли детского возраста – нейробластомы (НБ) и врожденных пороков сердца (ВПС), основанный на собственных и литературных данных. Анализ проведен на основании данных анамнеза и оценки эхокардиографического исследования (ЭХО-КГ) пациентов с установленным диагнозом «НБ», получавших лечение в НМИЦ детской гематологии, онкологии и иммунологии им. Дмитрия Рогачева Минздрава России. У 11 пациентов из 457 больных с НБ выявлен ВПС, наиболее частым из которых был дефект межжелудочковой перегородки. В статье рассмотрены эпидемиологические данные указанной когорты больных. Представлены детальное описание двух клинических случаев сочетания ВПС и локальной и метастатической формы НБ и обзор литературы, посвященной данной тематике. У пациентов с НБ был выявлен ВПС в 2,4% случаев. Все пациенты с НБ нуждаются в кардиологическом обследовании, включающем ЭХО-КГ.</p></trans-abstract><kwd-group xml:lang="en"><kwd>neuroblastoma</kwd><kwd>children</kwd><kwd>congenital heart disease</kwd><kwd>PHOX2B</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нейробластома</kwd><kwd>дети</kwd><kwd>врожденные пороки сердца</kwd><kwd>PHOX2B</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1.	Goodman M., Gurney J., Smith M., Olsham A. Sympathetic nervous system tumors. In: Ries LAG, Smith M, Gurney J, et al, (ed). Сancer incidence and survival amoung children and adolescents: United States SEER Program 1975–1995. Bethesda, Md: National Cancer Institute 1999; 65–72.</mixed-citation><mixed-citation xml:lang="ru">Goodman M., Gurney J., Smith M., Olsham A. Sympathetic nervous system tumors. In: Ries LAG, Smith M, Gurney J, et al, (ed). Сancer incidence and survival amoung children and adolescents: United States SEER Program 1975–1995. Bethesda, Md: National Cancer Institute 1999; 65–72.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2.	Narod S., Hawkins M., Robertson C., Stiller C. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997; 60(3): 474–85.</mixed-citation><mixed-citation xml:lang="ru">Narod S., Hawkins M., Robertson C., Stiller C. Congenital anomalies and childhood cancer in Great Britain. Am J Hum Genet 1997; 60(3): 474–85.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3.	George R., Lipshultz S., Lipsitz S., Colan S., Diller L. Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr 2004 Apr; 144 (4): 444–8.</mixed-citation><mixed-citation xml:lang="ru">George R., Lipshultz S., Lipsitz S., Colan S., Diller L. Association between congenital cardiovascular malformations and neuroblastoma. J Pediatr 2004 Apr; 144 (4): 444–8.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4.	Van Engelen K., Merks J., Lam J., Kremer L., Backes M., Baars M., et al. Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature. Eur J Pediatr 2009 Sep; 168 (9): 1081–9.</mixed-citation><mixed-citation xml:lang="ru">Van Engelen K., Merks J., Lam J., Kremer L., Backes M., Baars M., et al. Prevalence of congenital heart defects in neuroblastoma patients: a cohort study and systematic review of literature. Eur J Pediatr 2009 Sep; 168 (9): 1081–9.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5.	Schraw J.M. American Association for Cancer Research Annual Meeting; Abstract LB-161. 2018. Apr 14–18, Chicago.</mixed-citation><mixed-citation xml:lang="ru">Schraw J.M. American Association for Cancer Research Annual Meeting; Abstract LB-161. 2018. Apr 14–18, Chicago.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6.	Brodeur G., Pritchard J., Berthold F., Carlsen N., Castel V., Castelberry R., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11 (8): 1466–77.</mixed-citation><mixed-citation xml:lang="ru">Brodeur G., Pritchard J., Berthold F., Carlsen N., Castel V., Castelberry R., et al. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment. J Clin Oncol 1993; 11 (8): 1466–77.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7.	NB-2004 protocol. 01-Sept-2004.</mixed-citation><mixed-citation xml:lang="ru">NB-2004 protocol. 01-Sept-2004.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8.	Nomenclature of Diagnosis of Heart Diseases at NMMC; Ann Thorac Surg 2000.</mixed-citation><mixed-citation xml:lang="ru">Nomenclature of Diagnosis of Heart Diseases at NMMC; Ann Thorac Surg 2000.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9.	Beckwith J, Perrin E. In situ neuroblastomas: contribution to the natural history of neural crest tumors. Am J Pathol 1963 Dec; 43: 1089–104.</mixed-citation><mixed-citation xml:lang="ru">Beckwith J, Perrin E. In situ neuroblastomas: contribution to the natural history of neural crest tumors. Am J Pathol 1963 Dec; 43: 1089–104.</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">10.	de la Monte S.M., Hutchins G.M., Moore G.W. Peripheral neuroblastic tumors and congenital heart disease. Possible role of hypoxic states in tumor induction. Am J Pediatr Hematol Oncol 1985 Summer; 7 (2): 109–16.</mixed-citation><mixed-citation xml:lang="ru">de la Monte S.M., Hutchins G.M., Moore G.W. Peripheral neuroblastic tumors and congenital heart disease. Possible role of hypoxic states in tumor induction. Am J Pediatr Hematol Oncol 1985 Summer; 7 (2): 109–16.</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">11.	Ibrahim T.M.W., Gusztav B., Martin R., Wilf K. Congenital Neuroblastoma and Congenital Heart Disease. American Journal of Cancer Case Reports 2014 Feb 13; 2 (1): 1–5.</mixed-citation><mixed-citation xml:lang="ru">Ibrahim T.M.W., Gusztav B., Martin R., Wilf K. Congenital Neuroblastoma and Congenital Heart Disease. American Journal of Cancer Case Reports 2014 Feb 13; 2 (1): 1–5.</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">12.	Lin A., Ardinger H., Pierpont M. Clas-sification of cardiovascular malformations associated with neuroblastoma. J Pediatr 2005 Mar; 146 (3): 439–41.</mixed-citation><mixed-citation xml:lang="ru">Lin A., Ardinger H., Pierpont M. Clas-sification of cardiovascular malformations associated with neuroblastoma. J Pediatr 2005 Mar; 146 (3): 439–41.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">13.	Stefanski H., Wedel L., Haller C., Pierpont M., Perkins J. Is there an association between bicuspid aortic valve and neuroblastoma? Pediatr Blood Cancer 2010 Aug; 55 (2): 359–60.</mixed-citation><mixed-citation xml:lang="ru">Stefanski H., Wedel L., Haller C., Pierpont M., Perkins J. Is there an association between bicuspid aortic valve and neuroblastoma? Pediatr Blood Cancer 2010 Aug; 55 (2): 359–60.</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">14.	Martik M., Bronner M. Regulatory Logic Underlying Diversification of the Neural Crest. Trends Genet 2017 Oct; 33 (10): 715–27. Epub 2017 Aug 26.</mixed-citation><mixed-citation xml:lang="ru">Martik M., Bronner M. Regulatory Logic Underlying Diversification of the Neural Crest. Trends Genet 2017 Oct; 33 (10): 715–27. Epub 2017 Aug 26.</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">15.	Bolande R. Neoplasia of early life and its relationships to teratogenesis. Perspect Pediatr Pathol 1976, 3: 145–83.</mixed-citation><mixed-citation xml:lang="ru">Bolande R. Neoplasia of early life and its relationships to teratogenesis. Perspect Pediatr Pathol 1976, 3: 145–83.</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">16.	Le Dourain N. Migration and differentiation of neural crest cells. Curr Top Dev Biol 1980, 16: 31.</mixed-citation><mixed-citation xml:lang="ru">Le Dourain N. Migration and differentiation of neural crest cells. Curr Top Dev Biol 1980, 16: 31.</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">17.	Chatten J., Voorhess L. Familial neuroblastoma. N Engl J Med 1967; 277: 1230–6.</mixed-citation><mixed-citation xml:lang="ru">Chatten J., Voorhess L. Familial neuroblastoma. N Engl J Med 1967; 277: 1230–6.</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">18.	Ashley D.J.B. The two “hit” and multiple “hit” theories of carcinogenesis. Br J Cancer 1969; 23: 313.</mixed-citation><mixed-citation xml:lang="ru">Ashley D.J.B. The two “hit” and multiple “hit” theories of carcinogenesis. Br J Cancer 1969; 23: 313.</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">19.	Fryns P., Petit P., Moerman F., Cassiman J., van den Berghe H. 8p trisomy in a malformed foetus. Ann Genet 1982, 25: 162–3.</mixed-citation><mixed-citation xml:lang="ru">Fryns P., Petit P., Moerman F., Cassiman J., van den Berghe H. 8p trisomy in a malformed foetus. Ann Genet 1982, 25: 162–3.</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">20.	Matera I., Bachetti T., Puppo F., Di Duca M., Morandi F., Casiraghi G., et al. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet 2004 May; 41 (5): 373–80.</mixed-citation><mixed-citation xml:lang="ru">Matera I., Bachetti T., Puppo F., Di Duca M., Morandi F., Casiraghi G., et al. PHOX2B mutations and polyalanine expansions correlate with the severity of the respiratory phenotype and associated symptoms in both congenital and late onset Central Hypoventilation syndrome. J Med Genet 2004 May; 41 (5): 373–80.</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">21.	Lombardo R., Kramer E., Cnota J., Sawnani H., Hopkin R. Variable phenotype in a novel mutation in PHOX2B. Am J Med Genet A 2017 Jun; 173 (6): 1705–9.</mixed-citation><mixed-citation xml:lang="ru">Lombardo R., Kramer E., Cnota J., Sawnani H., Hopkin R. Variable phenotype in a novel mutation in PHOX2B. Am J Med Genet A 2017 Jun; 173 (6): 1705–9.</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">22.	Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 1999; 399 (6734): 366–70.</mixed-citation><mixed-citation xml:lang="ru">Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 1999; 399 (6734): 366–70.</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">23.	Качанов Д.Ю., Шаманская Т.В., Шевцов Д.В., Панкратьева Л.Л., Муф-тахова Г.М., Телешова М.В. и соавт. Генетическая предрасположенность к нейробластоме у детей: собственные данные и обзор литературы. Онкопедиатрия 2016; 3 (4): 277–87.</mixed-citation><mixed-citation xml:lang="ru">Качанов Д.Ю., Шаманская Т.В., Шевцов Д.В., Панкратьева Л.Л., Муф-тахова Г.М., Телешова М.В. и соавт. Генетическая предрасположенность к нейробластоме у детей: собственные данные и обзор литературы. Онкопедиатрия 2016; 3 (4): 277–87.</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">24.	Chow E.J., Friedman D.L., Mueller B.A. Maternal and perinatal characteristics in relation to neuroblastoma. Cancer 2007 Mar 1; 109 (5): 983–92.</mixed-citation><mixed-citation xml:lang="ru">Chow E.J., Friedman D.L., Mueller B.A. Maternal and perinatal characteristics in relation to neuroblastoma. Cancer 2007 Mar 1; 109 (5): 983–92.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">25.	Kitlinska J.B. Prenatal stress and neuroblastoma development – is there a link? http://grantome.com/grant/NIH/R21-CA198698-01. Online access 31.07.2018.</mixed-citation><mixed-citation xml:lang="ru">Kitlinska J.B. Prenatal stress and neuroblastoma development – is there a link? http://grantome.com/grant/NIH/R21-CA198698-01. Online access 31.07.2018.</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">26.	Narchi H., Kulaylat N. Heart disease in infants of diabetic mothers. Images Paediatr Cardiol 2000 Apr; 2 (2): 17–23.</mixed-citation><mixed-citation xml:lang="ru">Narchi H., Kulaylat N. Heart disease in infants of diabetic mothers. Images Paediatr Cardiol 2000 Apr; 2 (2): 17–23.</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">27.	Malik R.A., Lone M.R., Ahmed A., Koul K.A., Malla R.R. Maternal hyperhomocysteinemia and congenital heart defects: A prospective case control study in Indian population. Indian Heart J 2017 Jan–Feb; 69 (1): 17–19.</mixed-citation><mixed-citation xml:lang="ru">Malik R.A., Lone M.R., Ahmed A., Koul K.A., Malla R.R. Maternal hyperhomocysteinemia and congenital heart defects: A prospective case control study in Indian population. Indian Heart J 2017 Jan–Feb; 69 (1): 17–19.</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">28.	Molloy A.M., Kirke P.N., Brody L.C., Scott J.M., Mills J.L. Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr Bull 2008 Jun; 29 (2 Suppl): S101–11; discussion S112–5.</mixed-citation><mixed-citation xml:lang="ru">Molloy A.M., Kirke P.N., Brody L.C., Scott J.M., Mills J.L. Effects of folate and vitamin B12 deficiencies during pregnancy on fetal, infant, and child development. Food Nutr Bull 2008 Jun; 29 (2 Suppl): S101–11; discussion S112–5.</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">29. Holzer R., Franklin R. Congenital heart disease and neuroblastoma: just coincidence? Arch Dis Child 2002 Jul; 87 (1): 61–4.</mixed-citation><mixed-citation xml:lang="ru">Holzer R., Franklin R. Congenital heart disease and neuroblastoma: just coincidence? Arch Dis Child 2002 Jul; 87 (1): 61–4.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
